Radiopharm Theranostics (ASX:RAD) to start prostate cancer trial
07 Jul 2022 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari provides an update on the company's portfolio of therapies.